The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 3200 participants.

Also called NCT07905482

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 3,200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07905482
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07905482. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-05 (actual); primary completion 2029-03-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest
Acronym
REVIVE-PEEP
Condition
Cardiac Arrest, Out-Of-Hospital
Intervention (Device)
Fixed PEEP Valve
Intervention (Device)
Sham Valve
Lead sponsor
Jeroen van Eijk (class: other)
Collaborator
Dutch Heart Foundation (class: other)
Collaborator
Ambu A/S (class: industry)

Record details

Record id
cardio:ct-nct07905482
Content hash
a5b94c9ef778efc182b48d76f3cec96a1d37d5bc0ea8ff67dec484be02906421